Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

NEXT STORY
Novan Provides Enrollment Update and Announces New Corporate Headquarters
PREV STORY
NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Biomedical, Inc. Announces First Quarter 2017 Financial Results and Provides Corporate Update

ALPHARETTA, Ga., May 10, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News

New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted

Oasmia Pharmaceutical AB (Nasdaq: OASM) announces that the United States Patent and Trademark Office ...

author_avatar
NASDAQ Market News

Moleculin Announces Enrollment Opens for Brain Tumor Trial of WP1066

HOUSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or ...

author_avatar
NASDAQ Market News